PULMATRIX OPERATING COMPANY, INC.
Profile
Company Names
PULMATRIX OPERATING COMPANY, INC.
PULMATRIX INC
Addresses
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
Phone Numbers
(781) 357-2333
781-357-2333
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$47,574,150.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-06-15
$10,000,000.00
$34,124,543.00
$24,124,543.00
Equity
3
2015-03-13
$1,621,422.00
$1,621,422.00
$0.00
Equity
2
2011-08-02
$20,500,000.00
$24,000,000.00
$3,500,000.00
Debt
1
2009-10-16
$15,452,728.00
$30,294,395.00
$14,841,667.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT
CLARKE
EXECUTIVE OFFICER, DIRECTOR
ROBERT
CONNELLY
DIRECTOR
DAVID
EDWARDS
DIRECTOR
WD OFFSHORE FUND, LTD.
| PULMATRIX INC
| COMMUNITY + SOUTHERN HOLDINGS, INC.
| INNSMOUTH PARTNERS, LLC
| PULMATRIX OPERATING COMPANY, INC.
| QUANTUM DESIGNS, LLC
| ENTERPRISE HOUSING PARTNERS XXXIV LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XXXV LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XXXVI LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XXXVII LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XXXVIII LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS CALGREEN VIII FUND, L.P.
| SECOND ACT PARTNERS FUND I, L.P.
| ENTERPRISE EQUITABLE UPWARD MOBILITY FUND LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XXXIX LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XL LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XLI LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XLII CATHAY SUBFUND LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XLII LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS XLIII LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 44 LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 45 LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 46 LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 47 LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 48 LIMITED PARTNERSHIP
| ENTERPRISE HOUSING PARTNERS 49 LIMITED PARTNERSHIP
| SECOND ACT PARTNERS FUND II, L.P.
| ALBION TRINITY CAPITAL GZL FUND I, LP
| ATANA ELEMENTS INC
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
KURT
GRAVES
DIRECTOR
MICHAEL
HIGGINS
DIRECTOR
DAVID
MAKI
DIRECTOR
PULMATRIX INC
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ALTITUDE LIFE SCIENCE VENTURES SIDE FUND II, L.P.
| EFFECTOR THERAPEUTICS, INC.
| HDP I REIT LLC
| HEITMAN CORE REAL ESTATE DEBT INCOME TRUST, L.P.
| HEITMAN CREDIT REIT, LLC
| ALTITUDE LIFE SCIENCE VENTURES SIDE FUND III, L.P.
| APFC HCF HOLDINGS REIT LLC
| HEITMAN GLOBAL REAL ESTATE REIT LLC
| HEITMAN REAL ESTATE DEBT PARTNERS III, L.P.
| HEITMAN REAL ESTATE DEBT PARTNERS III-A, L.P.
| HEITMAN REAL ESTATE DEBT PARTNERS III-BLOCKER, L.P.
| HDP III REIT INVESTMENTS LLC
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
TERRY
MCGUIRE
DIRECTOR
SCOTT
ROCKLAGE
DIRECTOR
RENNOVIA INC
| PULMATRIX INC
| 5AM CO-INVESTORS III, L.P.
| ACHAOGEN INC
| RELYPSA INC
| WAVERX INC
| SEMPRUS BIOSCIENCES CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| KINESTRAL TECHNOLOGIES, INC.
| NOVIRA THERAPEUTICS, INC.
| 5AM CO-INVESTORS IV, L.P.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| EXPANSION THERAPEUTICS, INC.
| ALBAMUNITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

